Medication info
Vytorin 10/10

Vytorin 10/10

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
Bionex Co., Ltd.
Appearance
White to pale yellow, biconvex, rectangular tablets
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201007276 · Notified 2010.11.30 · Insurance code 643103210

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is taken once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg~10/40mg daily. The generally recommended starting dose is 10/20mg daily. Patients who require less LDL cholesterol reduction may start at 10/10mg daily. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken this medicine at 10/80 mg for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not suitable. Administration to patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration to patients with renal impairment and patients with chronic kidney disease No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine at 10/20mg once daily in the evening. Use caution and closely monitor these patients when administering higher doses of this medicine (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is required in elderly patients. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) This medicine should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed a dose of 10/20mg/day of this medicine.

Ingredients

Manufacturer
Bionex Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
View approved original text

This medication helps lower elevated total cholesterol and LDL cholesterol levels in patients with primary hypercholesterolemia, particularly heterozygous familial and non-familial hypercholesterolemia, reduce ApoB protein and triglycerides, and increase HDL cholesterol, which is considered 'good' cholesterol. It can also be used alone or in conjunction with other treatments for patients with homozygous familial hypercholesterolemia. This drug is used alongside non-drug measures such as dietary therapy, and appropriate treatment should be pursued after checking for other secondary causes. Patients with acute coronary events should have their cholesterol levels checked upon hospitalization, and treatment started if necessary. Overall, this medication plays a vital role in reducing risk factors associated with hypercholesterolemia and preventing cardiovascular diseases, thus being effectively used in the treatment of hypercholesterolemia.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is taken once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg~10/40mg daily. The generally recommended starting dose is 10/20mg daily. Patients who require less LDL cholesterol reduction may start at 10/10mg daily. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken this medicine at 10/80 mg for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not suitable. Administration to patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration to patients with renal impairment and patients with chronic kidney disease No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine at 10/20mg once daily in the evening. Use caution and closely monitor these patients when administering higher doses of this medicine (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is required in elderly patients. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) This medicine should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed a dose of 10/20mg/day of this medicine.

Precautions

This medication is primarily used to lower blood cholesterol levels. Caution should be exercised as muscle problems may arise while taking this medication. If muscle pain or weakness occurs, notify a doctor immediately. Patients with liver function problems or persistent unexplained increases in liver enzyme levels should not take this medication. Women who are pregnant or breastfeeding should not use this medication, and women of childbearing potential must confirm their pregnancy status before taking it. The risk of muscle problems or side effects may increase when this medication is taken with certain other drugs, so be sure to inform your doctor or pharmacist of any other medications you are taking. Elderly patients or those with decreased kidney function need to exercise greater caution when using this medication. Rarely, various side effects such as skin rashes, liver function abnormalities, gastrointestinal symptoms, headaches, dizziness, etc. may occur, and if symptoms persist or worsen, consult medical personnel. It is advisable to regularly monitor liver function and muscle status through blood tests while taking this medication. Additionally, this medication may not be suitable for patients with certain genetic disorders, thus the individual's health status should be thoroughly considered when using it.

Side effects

Myopathy, rhabdomyolysis, elevated creatine kinase, headache, diarrhea, influenza, upper respiratory tract infection, myalgia, limb pain, fatigue, abdominal pain, viral infection, pharyngitis, sinusitis, arthralgia, lumbago, cough, weakness, cataract, constipation, dyspepsia, flatulence, nausea, eczema, itching, rash, muscle cramps, specific cranial nerve dysfunction, dysgeusia, ocular motility disorder, facial partial paralysis, tremor, dizziness, sensory disturbance, peripheral neuropathy, peripheral nerve paralysis, psychiatric disorders, anxiety, sleep disorders, nightmares, depression, cognitive impairment, myasthenia gravis, ocular myasthenia, interstitial lung disease, anaphylaxis, urticaria, rash, angioedema, elevated hepatic aminotransferase levels, hepatitis, thrombocytopenia, nausea, pancreatitis, dizziness, cholelithiasis, cholecystitis, skin and mucous membrane syndrome, toxic epidermal necrolysis, eosinophilia, systemic symptom-associated drug reactions, erythema multiforme, drug-induced liver damage, alopecia, various skin changes, lichenoid drug eruption, gynecomastia, decreased libido, sexual dysfunction, ocular muscle paralysis, anemia, elevated aminotransferases, elevated ALP, elevated gamma-GT, elevated bilirubin levels, thyroid dysfunction, increased HbA1c, increased fasting blood glucose levels, edema, thirst, facial swelling, syncope, insomnia, gastritis, atrophic gastritis, mucous stools, irritable bowel syndrome, sore throat, nocturia, hematuria, weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a sealed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius to ensure the drug's efficacy is preserved and prevent deterioration.

Appearance and packaging

Appearance

White to pale yellow, biconvex, rectangular tablets

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.